Understand how NICE is supporting the Life Sciences sector in a rapidly evolving and complex policy landscape.
Hear about the impact of COVID-19 on NICE and its system partners and how this will influence future ways of working.
• Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation, NICE
• Carla Deakin, programme director, Commercial & Managed Access, NICE
• Eric Low, independent consultant
• Additional speakers to be announced